242 related articles for article (PubMed ID: 25233847)
1. Intracystic bleomycin for cystic craniopharyngiomas in children.
Zheng J; Fang Y; Cai BW; Zhang H; Liu W; Wu B; Xu JG; You C
Cochrane Database Syst Rev; 2014 Sep; (9):CD008890. PubMed ID: 25233847
[TBL] [Abstract][Full Text] [Related]
2. Intracystic bleomycin for cystic craniopharyngiomas in children.
Zhang S; Fang Y; Cai BW; Xu JG; You C
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008890. PubMed ID: 27416004
[TBL] [Abstract][Full Text] [Related]
3. Intracystic bleomycin for cystic craniopharyngiomas in children.
Fang Y; Cai BW; Zhang H; Liu W; Wu B; Xu JG; You C
Cochrane Database Syst Rev; 2012 Apr; (4):CD008890. PubMed ID: 22513968
[TBL] [Abstract][Full Text] [Related]
4. Intracystic bleomycin for cystic craniopharyngiomas in children (abridged republication of cochrane systematic review).
Liu W; Fang Y; Cai B; Xu J; You C; Zhang H
Neurosurgery; 2012 Nov; 71(5):909-15. PubMed ID: 22902333
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
6. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
7. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for children with medulloblastoma.
Michiels EM; Schouten-Van Meeteren AY; Doz F; Janssens GO; van Dalen EC
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006678. PubMed ID: 25879092
[TBL] [Abstract][Full Text] [Related]
9. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
[TBL] [Abstract][Full Text] [Related]
10. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
Cheuk DK; Chiang AK; Chan GC; Ha SY
Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children.
Hader WJ; Steinbok P; Hukin J; Fryer C
Pediatr Neurosurg; 2000 Oct; 33(4):211-8. PubMed ID: 11124639
[TBL] [Abstract][Full Text] [Related]
13. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707
[TBL] [Abstract][Full Text] [Related]
14. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC; Raphaël MF; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2014 Sep; (9):CD006647. PubMed ID: 25188452
[TBL] [Abstract][Full Text] [Related]
15. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
[TBL] [Abstract][Full Text] [Related]
16. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257
[TBL] [Abstract][Full Text] [Related]
17. Commentary: intracystic bleomycin for cystic craniopharyngiomas in children (abridged republication of cochrane systematic review).
Wisoff JH
Neurosurgery; 2012 Nov; 71(5):E1063-4. PubMed ID: 22902336
[No Abstract] [Full Text] [Related]
18. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010885. PubMed ID: 31961948
[TBL] [Abstract][Full Text] [Related]
19. Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience.
Hukin J; Steinbok P; Lafay-Cousin L; Hendson G; Strother D; Mercier C; Samson Y; Howes W; Bouffet E
Cancer; 2007 May; 109(10):2124-31. PubMed ID: 17407137
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
